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Abstract
(+)-Totarol, a highly hydrophobic diterpenoid isolated from Podocarpus spp., is inhibitory towards the growth of diverse
bacterial species. (+)-Totarol decreased the onset temperature of the gel to liquid-crystalline phase transition of DMPC and
DMPG membranes and was immiscible with these lipids in the fluid phase at concentrations greater than 5 mol%. Different
(+)-totarol/phospholipid mixtures having different stoichiometries appear to coexist with the pure phospholipid in the fluid
phase. At concentrations greater than 15 mol% (+)-totarol completely suppressed the gel to liquid-crystalline phase transition
in both DMPC and DMPG vesicles. Incorporation of increasing amounts of (+)-totarol into DEPE vesicles induced the
appearance of the HII hexagonal phase at low temperatures in accordance with NMR data. At (+)-totarol concentrations
between 5 and 35 mol% complex thermograms were observed, with new immiscible phases appearing at temperatures below
the main transition of DEPE. Steady-state fluorescence anisotropy measurements showed that (+)-totarol decreased and
increased the structural order of the phospholipid bilayer below and above the main gel to liquid-crystalline phase transition
of DMPC respectively. The changes that (+)-totarol promotes in the physical properties of model membranes, compromising
the functional integrity of the cell membrane, could explain its antibacterial effects. ß 2001 Elsevier Science B.V. All rights
reserved.
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1. Introduction
Use of plants and plant products for medicinal
purposes has roots tracing back to prehistoric times
[1]. Amongst the classes of compounds that have
proven to be of ethno-pharmacological importance
are terpenoids, whose antimicrobial [2^8], antitumor-
al [9,10], anti-in£ammatory [11] and cardiovascular
[9,12] activities are the most representative biological
activities described for these types of compounds.
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Abbreviations: Grf, steady-state £uorescence anisotropy; vH,
enthalpy change; vc, chemical shift anisotropy; DEPE, 1,2-di-
elaidoyl-sn-glycero-3-phosphoethanolamine; DMPC, 1,2-dimyris-
toyl-sn-glycero-3-phosphocholine; DMPG, 1,2-dimyristoyl-sn-
glycero-3-[phospho-rac-glycerol] ; DSC, di¡erential scanning cal-
orimetry; 31P-NMR, phosphorus nuclear magnetic resonance;
PA-DPH, 3-(p-6-phenyl-1,3,5-hexatrienyl)phenylpropionic acid;
Tc, onset temperature of the gel to liquid-crystalline phase tran-
sition
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During studies on the e¡ects of phenolics towards
oral microorganisms it has been observed that (+)-
totarol (14-isopropyl-8,11,13-podocarpatrien-13-ol,
see Fig. 1), a diterpenoid isolated from Podocarpus
spp. and other plants, is an extremely potent inhib-
itor of supra- and subgingival bacteria [13]. (+)-To-
tarol, apart from being inhibitory towards the
growth of diverse bacterial species [13^15], has also
been shown to be e¡ective against oxidative stress
[16]. Other diterpenoids, particularly kauranes and
secokauranes isolated from leaves of Rabdosia tricho-
carpa, also inhibit oral streptococci and the perio-
dontopathogen Porphyromonas gingivalis [17]. Their
mode(s) of action, as well as that of (+)-totarol, have
not yet been described.
(+)-Totarol is a hydrocarbon containing a single
phenolic moiety with an isopropyl group ortho to the
hydroxyl group (Fig. 1). The minimal inhibitory con-
centration of (+)-totarol is some two orders of mag-
nitude lower than that of thymol (unpublished re-
sults), a monoterpene commonly used as an oral
antiseptic, with which (+)-totarol shares some struc-
tural features. While Haraguchi and co-workers [18]
claimed that (+)-totarol functions at the level of en-
ergy-coupled bacterial respiration, (+)-totarol inhib-
ited the growth of both facultative and obligate an-
aerobes cultured under strictly anaerobic conditions
[13]. (+)-Totarol presents some similarities with thy-
mol, although the hydrophobicity of (+)-totarol is
much greater than that of thymol [19]. From the
fact that thymol’s principal mode of action is most
likely through membrane rupture with ensuing leak-
age of intracellular constituents and collapse of
transmembrane potentials [20] and from recent re-
sults of our group which show that (+)-totarol is
embedded in the membrane [19], it seems reasonable
to think that the mode of action of (+)-totarol might
be at least partly attributable to its speci¢c e¡ect on
membrane structure. Therefore, we have carried out
a detailed study on the interaction of (+)-totarol with
phospholipid model membranes composed of 1,2-
dimyristoyl-sn-glycero-3-phosphocholine (DMPC),
1,2-dimyristoyl-sn-glycero-3-[phospho-rac-glycerol]
(DMPG) and dielaidoyl-sn-glycero-3-phosphoetha-
nolamine (DEPE) using di¡erential scanning calo-
rimetry (DSC), steady-state £uorescence anisotropy,
small-angle X-ray di¡raction and phosphorus nu-
clear magnetic resonance (31P-NMR). The results ob-
tained in this work suggest that the potent antibac-
terial e¡ects of (+)-totarol might be likely mediated
by the formation of perturbed membrane structures.
2. Materials and methods
2.1. Chemicals
DMPC, DMPG and DEPE were obtained from
Avanti Polar Lipids (Birmingham, AL, USA). Stock
solutions were prepared in chloroform/methanol
(2:1) and stored at 320‡C. (+)-Totarol was pur-
chased from Industrial Research (Lower Hutt, New
Zealand), and 3-(4-(6-phenyl)-1,3,5-hexatrienyl)phe-
nylpropionic acid (PA-DPH) from Molecular Probes
(Eugene, OR, USA). Water was twice-distilled in an
all-glass apparatus and deionized using Milli-Q
equipment (Millipore, Bedford, MA, USA). All other
compounds were of analytical reagent grade.
2.2. Di¡erential scanning calorimetry
Chloroform/methanol solutions containing 2.4
Wmol of total phospholipid (DMPC, DMPG or
DEPE) and the appropriate amount of (+)-totarol
were dried under a stream of oxygen-free N2 to ob-
tain a thin ¢lm at the bottom of a small thick-walled
glass tube, and the last traces of solvent were re-
moved by keeping the samples under high vacuum
for more than 3 h. Multilamellar vesicles were
formed by incubating the dried lipid on 1.6 ml of
bu¡er (10 mM HEPES, pH 7.4, 100 mM NaCl, 0.1
mM EDTA bu¡er) for 15 min at a temperature
above the gel to liquid-crystalline transition (but be-
low the temperature of the lamellar liquid-crystalline
to hexagonal-HII transition for DEPE containing
vesicles) with occasional and vigorous vortexing.
Thermograms were recorded on a high-resolution
Microcal MC-2 di¡erential scanning microcalorime-
ter, equipped with a DA-2 digital interface and data
acquisition utility for automatic data collection. Dif-
ferences in the heat capacity between the sample and
the reference cell, which contained only bu¡er, were
obtained by raising the temperature at a constant
rate of 1‡C/min over the range from 8‡C to 45‡C
for samples containing DMPC or DMPG, or from
15‡C to 75‡C for samples containing DEPE. A series
BBAMEM 78060 22-3-01
V. Micol et al. / Biochimica et Biophysica Acta 1511 (2001) 281^290282
of three consecutive scans of the same sample were
performed to ensure scan-to-scan reproducibility.
Unless otherwise stated, the third scan was used for
transition and enthalpy calculations. After the ther-
mal measurements the phospholipid content of the
sample volume was determined [21]. Partial phase
diagrams for the phospholipid components were con-
structed as previously described [22]. The onset and
completion temperatures of the transition peaks ob-
tained from heating scans de¢ned the solidus and
£uidus lines of the diagrams.
2.3. 31P-Nuclear magnetic resonance spectroscopy
For NMR analysis, 30 Wmol of the phospholipid
and the appropriate amount of (+)-totarol were
mixed in chloroform and evaporated to dryness
under a stream of oxygen-free N2. The remaining
traces of solvent were removed by storage for 5 h
under high vacuum. HEPES bu¡er (0.3 ml) was
added to the dry lipid mixtures and the samples
were heated at a temperature above the transition
temperature for 30 min with occasional and vigorous
vortexing. The suspensions were transferred into con-
ventional 5 mm NMR tubes and 31P-NMR spectra
were obtained in the Fourier transform mode at dif-
ferent temperatures in a Varian Unity 300 spectrom-
eter. All chemical shift values were quoted in parts
per million (ppm) with reference to pure lysophos-
phatidylcholine micelles (0 ppm), positive values re-
ferring to low-¢eld shifts. All spectra were obtained
in the presence of a gated-broad band proton decou-
pling (10 W input power during acquisition time)
and accumulated free induction decays were obtained
from up to 2000 scans. A spectral width of 25 000
Hz, a memory of 32K data points, a 2 s interpulse
time and an 80‡ radio frequency pulse were used.
Prior to Fourier transformation, an exponential mul-
tiplication was applied resulting in a 100 Hz line
broadening. The residual chemical shift anisotropy,
vc, was calculated as 3 times the chemical shift dif-
ference between the high-¢eld peak and the position
of isotropically moving lipid molecules at 0 ppm [22].
2.4. Fluorescence spectroscopy
DMPC vesicles containing di¡erent (+)-totarol
concentrations were prepared as described for DSC
measurements. Aliquots of PA-DPH in N,NP-dimeth-
ylformamide (2U1034 M) were directly added to
the lipid dispersion to obtain a probe/lipid molar
ratio of 1:500. Samples were incubated well above
the gel to liquid-crystalline phase transition temper-
ature for 10 min and measurements were carried out
immediately thereafter. Steady-state £uorescence ani-
sotropy, Grf, of PA-DPH was measured at di¡erent
temperatures using an SLM-8000C spectro£uorime-
ter ¢tted with Glan-Thompson polarizers. The verti-
cal and horizontally polarized emission intensities,
elicited by vertically polarized excitation, were cor-
rected for background scattering by subtracting the
corresponding polarized intensities of a blank con-
taining the unlabelled preparation. The G-factor,
which accounts for the di¡erential polarization sen-
sitivity, was determined by measuring the polarized
components of £uorescence of the probe with hori-
zontally polarized excitation. Samples were excited at
350 nm (slit width, 1 nm) and £uorescence emission
was recorded at 450 nm (slit width, 4 nm).
2.5. Small-angle X-ray di¡raction
Samples for X-ray di¡raction analysis were pre-
pared essentially as described for DSC. Usually 10^
15 mg of lipid were dried and resuspended in 1 ml of
HEPES bu¡er, pelleted down in a bench microfuge
and placed in the X-ray di¡ractometer sample hold-
er. Nickel-¢ltered Cu KK X-rays (V= 1.54 Aî ) were
produced using a Philips generator (PW1830). X-
Rays were focussed using a £at gold-plated mirror.
Lipid dispersions were irradiated in aluminium hold-
ers with Mylar windows and di¡ractograms recorded
using a linear position-sensitive detector (model 210,
Bio-Logic, Grenoble, France). The sample tempera-
ture was kept within þ 0.5‡C, using a circulating
water bath, and the system was allowed to equili-
brate for about 5 min at each temperature before
measurements. The X-ray exposure times were typi-
cally 10^15 min for each sample. Calibration of the
detector was carried out using crystalline cholesterol
(d-spacing = 33.6 Aî ).
3. Results
The e¡ect of (+)-totarol on the thermotropic be-
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haviour of either DMPC or DMPG vesicles has been
studied by DSC as shown in Fig. 2A and B, respec-
tively. Addition of a low concentration (0.5 mol%) of
(+)-totarol drastically broadened the pretransition
and slightly broadened the main gel to liquid-crystal-
line transition signal of DMPC (Fig. 2A). At (+)-
totarol concentrations equal or greater than 2 mol%
there is a complete disappearance of the pretransition
signal and a shift of the main transition signal of
DMPC towards lower temperatures. Within the
range 5^15 mol% (+)-totarol complex patterns were
observed, with a progressively downward Tc shift,
and the appearance of broad new peaks located
near to the gel to liquid-crystalline phase transition
signal of DMPC. At 10 mol% (+)-totarol the transi-
tion has a broad, complex shape with a maximum at
21‡C, although a shoulder discerned at higher tem-
peratures indicates the presence of at least two di¡er-
ent phospholipid populations. A very broad pro¢le
was observed at 15 mol% (+)-totarol, and the main
phase transition was completely abolished at 30
mol% (+)-totarol.
A similar behaviour was observed for DMPG
vesicles in the presence of increasing amounts of
(+)-totarol (Fig. 2B). The pretransition was abol-
ished at very low concentrations of (+)-totarol and
the main transition shifted to lower temperatures
upon increasing its concentration. On going from 2
to 15 mol% (+)-totarol the transition progressively
broadened but did not show the complex patterns
observed in the DMPC samples. As it was found
for DMPC, the main phase transition of DMPG
was completely abolished at a concentration of 30
mol% (+)-totarol.
Fig. 2. Di¡erential scanning calorimetry heating-scan thermograms for mixtures of (+)-totarol plus (A) DMPC and (B) DMPG. Each
sample contained the appropriate amount of (+)-totarol (molar % of total) as indicated on the curves.
Fig. 1. Chemical structure of (+)-totarol (14-isopropyl-8,11,13-
podocarpatrien-13-ol).
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We have studied the presence of (+)-totarol-in-
duced membrane perturbations on model membranes
composed of DEPE by DSC (Fig. 3). Aqueous dis-
persions of DEPE can undergo a gel to liquid-crys-
talline (LLCLK) phase transition in the lamellar
phase (approx. 37‡C) and, in addition, a lamellar
liquid-crystalline to hexagonal-HII (LKCHII) transi-
tion (approx. 65‡C) [23]. In the presence of concen-
trations of (+)-totarol as low as 0.5 mol%, a new
transition occurs at the low-temperature side of the
main gel-to-liquid phase transition (around 34‡C)
(Fig. 3). This new peak increased in area at the ex-
pense of the main peak when the amount of (+)-
totarol was increased, and became the predominant
peak at a concentration of 5 mol% (+)-totarol. At
5 mol% another small peak was apparent at approx.
24‡C. At (+)-totarol concentrations between 5 and 35
mol% complex thermograms were observed, with
new phases appearing at temperatures below the
main phase transition temperature of the phospho-
lipid. At 20 mol% (+)-totarol the sharp peak found
at 34‡C was no longer observed and a broad transi-
tion coexisted with the 24‡C peak. At 35 mol% (+)-
totarol only one transition was observed (Fig. 3).
Incorporation of increasing amounts of (+)-totarol
into DEPE vesicles stabilized the HII hexagonal
phase: the LKCHII phase transition gradually de-
creased from 0.5 to 2 mol% (+)-totarol and was no
longer apparent above 2 mol% (+)-totarol (Fig. 3).
The e¡ects of (+)-totarol on the transition enthal-
pies (vH) of the main gel to liquid-crystalline phase
transitions of DMPC, DMPG and DEPE were also
determined (Table 1). For DMPC and DMPG, the
vH decreased as a function of increasing concentra-
tions of (+)-totarol until a concentration of 30 mol%
(+)-totarol was reached, when the transitions disap-
peared. This decrease in vH was nearly linear, de-
spite the fact that several peaks with di¡erent widths
were found in the thermograms at di¡erent phospho-
lipid/(+)-totarol molar ratios. A decrease in vH was
also found for DEPE as a function of increasing
concentrations of (+)-totarol, but it was not as sig-
ni¢cant as that found for DMPC and DMPG. We
have calculated the average number of phospholipid
molecules per molecule of (+)-totarol as described
previously [24], obtaining values of 4.2 þ 0.3,
4.6 þ 0.23 and 1.9 þ 0.26 for DMPC, DMPG and
DEPE respectively.
To discern how (+)-totarol could a¡ect the phase
behaviour of DMPC and DEPE we have carried out
31P-NMR measurements at di¡erent temperatures.
31P-NMR is sensitive to local motion and orientation
of the phosphate group in membrane phospholipids,
and the macroscopic environment of the whole mol-
ecule determines the line shape of the 31P-NMR spec-
trum [25]. This phase sensitivity makes 31P-NMR a
very suitable tool to follow the structural changes in
biological and model membranes. DMPC and
DEPE, when organized in bilayer structures, give
rise to an asymmetrical 31P-NMR line shape with a
high-¢eld peak and a low-¢eld shoulder, presenting a
residual chemical shift anisotropy, vc, of around 36^
Fig. 3. Di¡erential scanning calorimetry heating-scan thermo-
grams for mixtures of (+)-totarol plus DEPE. Each sample con-
tained the appropriate amount of (+)-totarol (molar % of total)
as indicated on the curves.
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40 ppm in the gel state and approx. 27^30 ppm in the
liquid-crystalline state. In the HII phase, due to rapid
lateral di¡usion of the phospholipid around the tubes
of which this phase is composed, the chemical shift
anisotropy is further averaged resulting in a line
shape with reverse symmetry, i.e., a high-¢eld
shoulder and a low-¢eld peak, with a 2-fold reduc-
tion in the absolute value of vc [22]. Incorporation
of (+)-totarol in DMPC membranes did not induce
any signi¢cant change in the line shape of the 31P-
NMR spectra when compared to the pure phospho-
lipid (not shown for briefness). However, DEPE
membranes containing as low as 2 mol% of (+)-to-
tarol showed a signal corresponding to the hexago-
nal-HII phase superimposed to a bilayer signal at
temperatures much lower than that of the pure phos-
pholipid (Fig. 4). At a concentration of 10 mol% of
(+)-totarol, a signal corresponding to the hexagonal-
HII phase was observed at temperatures as low as
22‡C.
The e¡ect of the incorporation of (+)-totarol on
the phase adopted by the phospholipid membranes
at di¡erent temperatures has also been studied by
small-angle X-ray di¡raction. In the case of DMPC
model membranes and mixtures containing (+)-totar-
ol (not shown), the ¢rst and second order re£ections
appeared at a ratio of the lattice parameter of 1:1/2,
indicating that the systems were always in the lamel-
Fig. 4. 31P-NMR spectra of aqueous dispersions of mixtures of DEPE plus (+)-totarol as a function of temperature. (A) Pure DEPE;
(B) DEPE plus 2 mol% (+)-totarol ; (C) DEPE plus 10 mol% (+)-totarol. Spectra have been normalized and temperatures are indi-
cated on the spectra.
Table 1
Enthalpy changes (vH, kcal/mol) for mixtures containing (+)-totarol and DMPC, DMPG and DEPE at di¡erent (+)-totarol mol frac-
tions
Totarol mol fraction vH (kcal/mol) Totarol mol fraction vH (kcal/mol)
DMPC DMPG DEPE
0 5.9 6.9 0 8.3
0.005 5.6 6.6 0.005 7.4
0.01 5.0 6.3 0.01 7.0
0.02 4.9 6.1 0.02 6.5
0.05 4.2 5.5 0.05 7.4
0.10 4.0 3.3 0.1 6.15
0.15 2.0 2.5 0.2 5.45
0.25 6.2
0.35 5.9
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lar state [26]. The results shown in Fig. 5 for pure
DEPE model membranes indicate that between 15‡C
and 55‡C pure DEPE adopts a lamellar structure,
but at 70‡C adopts a hexagonal-HII structure with
re£ections appearing at a ratio of 1 : 1=

3
p
[26]. The
incorporation of 2 mol % of (+)-totarol induced the
coexistence of both lamellar and HII phases at 55‡C
(Fig. 5), whereas a concentration of 10 mol% of (+)-
totarol induced the coexistence of both lamellar and
HII phases at much lower temperatures, in accor-
dance with the NMR results shown above (Fig. 4).
There were also no signi¢cant di¡erences in the d-
spacings imposed by the presence of (+)-totarol when
compared with either pure DMPC or pure DEPE,
indicating that the (+)-totarol did not change the
interbilayer repeat distance in either type of mem-
brane.
The e¡ect of (+)-totarol on the structural order of
lipid membranes was investigated by measuring as a
function of temperature the steady-state £uorescence
anisotropy, Grf, of PA-DPH incorporated in DMPC
vesicles and containing di¡erent mole fractions of
(+)-totarol. PA-DPH is a very useful molecule to
study the structural order of the lipid bilayer since
it anchors at the aqueous interface of phospholipid
membranes by its carboxylate group whilst its £uo-
rescent diphenylhexatrienyl moiety intercalates be-
tween the phospholipid acyl chains [27,28]. For
pure DMPC, Grf decreased slightly with increasing
temperature, with a sharp drop occurring at 23‡C,
the Tc temperature (Fig. 6). Increasing gradually
Fig. 7. Partial phase diagram for mixtures of DEPE plus (+)-
totarol. Open circles correspond to the lamellar solidus line and
¢lled circles to the lamellar £uidus line. Open squares depict
the £uid-lamellar/hexagonal-HII boundary and ¢lled squares the
£uid-lamellar+hexagonal-HII/hexagonal-HII boundary. G corre-
sponds to a lamellar phase, F to a lamellar £uid phase and HII
to the hexagonal-HII phase (see text for details).
Fig. 6. Steady-state anisotropy, Grf, of PA-DPH in aqueous dis-
persions of DMPC plus (+)-totarol as a function of tempera-
ture for (a) pure DMPC and DMPC with (+)-totarol at molar
percentages of (+)-totarol of (b) 5%, (F) 10%, (R) 15% and
(E) 30%. The insert shows the ¢rst derivative of the Grf plots
(see text for details).
Fig. 5. X-Ray di¡raction patterns for aqueous dispersions of
DEPE and DEPE plus (+)-totarol at the temperatures shown.
(A) Pure DEPE; (B) DEPE plus 2 mol% (+)-totarol ; (C)
DEPE plus 10 mol% (+)-totarol. d-Spacings (Aî ) are plotted on
a logarithmic scale.
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the mole fraction of (+)-totarol up to 30 mol% it
abolished the LLCLK phase transition and shifted
it to lower temperatures (Fig. 6) in agreement with
the DSC data. At temperatures below the main gel to
liquid-crystalline phase transition it diminished the
structural order of the phospholipid bilayer and at
temperatures above it made the £uid phase more
ordered. At 30 mol% of (+)-totarol no transition
was observed (Fig. 6). A similar e¡ect has been re-
ported for DMPC/cholesterol mixtures using di¡er-
ent methods [29] and this supports the idea that (+)-
totarol intercalates between the phospholipid hydro-
carbon chains [19]. The behaviour observed at a con-
centration of 10 mol% (+)-totarol (see insert in Fig.
6) suggests the presence in the bilayer of di¡erent
phospholipid domains, as previously indicated by
the DSC experiments (Fig. 2A).
4. Discussion
The diterpenoid (+)-totarol is bacteriostatic to-
wards a wide assortment of oral bacteria [13] and
has a very high lipid/water partition coe⁄cient Kp
[19]. Although thymol, a bacteriostatic monoterpe-
noid, shares some structural features with (+)-totar-
ol, its lipid/water partition coe⁄cient is much lower
than that of (+)-totarol [19]. The di¡erences in lipid/
water partition coe⁄cients of both molecules imply
that lower concentrations of exogenous (+)-totarol
would be required to achieve a ‘critical’ intramem-
branous concentration compared to thymol. Ac-
tually, we have found that lower concentrations of
(+)-totarol are necessary to show bacteriostatic activ-
ity against di¡erent oral bacteria than those of thy-
mol (in preparation). Since (+)-totarol is embedded
in the phospholipid palisade of the membrane, with
the phenol group located distant to the phospholipid/
water interface [19], and is a larger molecule than
thymol, (+)-totarol may promote a greater degree
of destabilization per molecule intercalated into the
para⁄nic core of the membrane [15,30,31].
DSC data indicate that (+)-totarol disrupts the
packing of the phospholipids, since it perturbed the
cooperativity of the phase transitions of both DMPC
and DMPG at concentrations as low as 2 mol%.
This phenomenon could be explained in terms of
intercalation of the diterpenoid between the phos-
pholipid molecules. A similar arrangement has been
postulated for the diterpene resin acid abietic acid
[22,32], which localizes its polar group (-COOH) in
close proximity to the phospholipid ester moieties so
that the molecule does not extend into the phospho-
lipid bilayer beyond the C-4/C-7 carbons of the phos-
pholipid molecule. At higher concentrations of (+)-
totarol, e.g. 10 mol%, several membrane components
were observed, probably due to a lateral phase sep-
aration of (+)-totarol rich domains. The decrease in
Tc of membrane components was also accompanied
by a decrease in vH, indicating that (+)-totarol per-
turbs the packing and interaction between the phos-
pholipids. It has been described recently that di¡er-
ent n-(9-anthroyloxy)stearic acid £uorescent probes
could be incorporated e⁄ciently into bacterial plas-
ma membranes during the growth phase attaining
high concentrations, i.e., between 7 and 13% [33].
As described above, lower concentrations of (+)-to-
tarol than these ones have signi¢cant e¡ects on phos-
pholipid membrane structure.
DSC, 31P-NMR, and small-angle X-ray di¡rac-
tion were used to elucidate the molecular basis of
the interactions between (+)-totarol and DMPC,
DMPG and DEPE membranes, to characterize the
possible modulation by (+)-totarol on the macro-
scopic organization of the phospholipids and con-
struct the corresponding phase diagrams. The phase
diagram for di¡erent DMPC/(+)-totarol aqueous dis-
persions (not shown for briefness) showed that the
temperature of the solidus line decreased with in-
creasing concentration of (+)-totarol, while the £u-
idus line slightly decreased up through 5 mol%. A
temperature increase was subsequently observed on
going from 5 to 15 mol% (+)-totarol, indicating the
likely presence of two di¡erent phospholipid do-
mains in the £uid phase. In the region de¢ned by
the coexistence of the gel and £uid phases (G+F)
at least two phospholipid domains coexist, since at
least two peaks were observed. The behaviour of the
solidus line in the partial phase diagram for DMPG
plus (+)-totarol (not shown) was similar to that de-
scribed for DMPC plus (+)-totarol, but the £uidus
line decreased slightly up to 15 mol% (+)-totarol. In
both phase diagrams the phospholipid component
evolved from a lamellar gel phase to a lamellar liq-
uid-crystalline phase via a broad region of phase co-
existence.
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More complex phase behaviour was noted in mix-
tures containing DEPE plus (+)-totarol, as shown by
the corresponding phase diagram (Fig. 7). At con-
centrations of (+)-totarol greater than 2 mol% the
LKCHII phase transition peak was not observed
due to broadening, though a shift to much lower
temperatures could still be demonstrated by 31P-
NMR spectroscopy and X-ray di¡raction (Figs. 4
and 5). Up to 2 mol% (+)-totarol the £uidus line
corresponding to the LLCLK phase transition dis-
played immiscibility in the £uid state, indicating the
presence of a DEPE/(+)-totarol domain coexisting
with free phospholipid. At about 2 mol% of totarol,
a complex pattern corresponding to domains with
di¡erent DEPE/(+)-totarol stoichiometries were ob-
served. In the region de¢ned by G+F there coexist
two gel and £uid phases, but in the region de¢ned by
G+HII at least three peaks were observed (Fig. 3). At
high concentrations of (+)-totarol, it appears that the
LKCHII phase transition occurred at about the same
temperature as the LLCLK phase transition. The
31P-NMR data support this interpretation and
show that (+)-totarol promotes formation of the hex-
agonal-HII phase at temperatures below the Tc of
pure DEPE. The inclusion of (+)-totarol in the
DEPE membranes perturbs the lipid matrix and in-
creases the acyl chain motion, which e¡ectively in-
creases the hydrophobic volume per molecule. Con-
sequently, the formation of hexagonal structures
would be facilitated by a large packing parameter
[34]. Location of (+)-totarol in the phospholipid bi-
layers should be compatible with its ability to per-
turb phospholipid model membranes. The £uores-
cence anisotropy data show that low concentrations
of (+)-totarol have strong e¡ects on the anisotropy
of PA-DPH, so that the diterpenoid is immersed in
the phospholipid palisade and probably aligned
along the phospholipid chains, with its phenol group
located distant to the phospholipid/water interface
[19].
Bacterial membranes contain signi¢cant amounts
of lipids which can form inverted hexagonal-HII
phases, such as diacylglycerols, phosphatidylethanol-
amines and phosphatidylglycerols [35,36]. The results
of the present work, i.e., the complex thermotropic
behaviour of phospholipid membranes containing
(+)-totarol indicative of the formation of perturbed
membrane structures and the ability of (+)-totarol in
promoting the hexagonal phase at low temperatures,
indicate that the bactericidal and bacteriostatic ac-
tions of (+)-totarol could be likely mediated through
its interaction with the bacterial membrane. Work is
in progress to elucidate the mechanism of its anti-
bacterial activity in vivo.
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